Safety and tolerability of intravenous immunoglobulins.
Martin
T D
TD
Octapharma Pharmazeutika Produktions, Vienna, Austria.
D003711:Demyelinating Diseases / Q000276:immunology / Q000628:therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage* / Q000009:adverse effects*; D009157:Myasthenia Gravis / Q000276:immunology / Q000628:therapy*
D016756:Immunoglobulins, Intravenous